APA (7th ed.) Citation

Li, L., Wen, Q., & Ding, R. (2022). Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials. Frontiers in oncology, 12, 905520. https://doi.org/10.3389/fonc.2022.905520

Chicago Style (17th ed.) Citation

Li, Linwei, Qinglian Wen, and Ruilin Ding. "Therapeutic Targeting of VEGF And/or TGF-β to Enhance Anti-PD-(L)1 Therapy: The Evidence from Clinical Trials." Frontiers in Oncology 12 (2022): 905520. https://doi.org/10.3389/fonc.2022.905520.

MLA (9th ed.) Citation

Li, Linwei, et al. "Therapeutic Targeting of VEGF And/or TGF-β to Enhance Anti-PD-(L)1 Therapy: The Evidence from Clinical Trials." Frontiers in Oncology, vol. 12, 2022, p. 905520, https://doi.org/10.3389/fonc.2022.905520.